Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The fate of new fosfamides in phase iii studies in advanced soft tissue sarcoma
As scientists continue to search for therapies that reverse or halt neurological deterioration, one compound is showing exceptional promise Dihexa
10.1016/j.celrep.2014.04.045 137 LanJ.TaiH
Prospective Study of Methylenetetrahydrofolate Reductase (MTHFR) Variant C677T and Risk of All-Cause and Cardiovascular Disease Mortality among 6000 US Adults. The American Journal of Clinical Nutrition, vol
US$ 24.53
US$ 21.79
US$ 25.46
US$ 21.70
US$ 26.94
